To validate this association, we conducted survival analysis using the cBioPortal database, which revealed significantly prolonged overall survival in CRC patients with high FXR expression compared to those with low FXR levels (Fig. 4A). The gene discussed is NR1H4; the disease is colorectal carcinoma.